Activation of the Nrf-2/HO-1 signalling axis can alleviate metabolic syndrome in cardiovascular disease
- PMID: 38039549
- PMCID: PMC10836253
- DOI: 10.1080/07853890.2023.2284890
Activation of the Nrf-2/HO-1 signalling axis can alleviate metabolic syndrome in cardiovascular disease
Abstract
Background: Cardiovascular disease (CVD) is widely observed in modern society. CVDs are responsible for the majority of fatalities, with heart attacks and strokes accounting for approximately 80% of these cases. Furthermore, a significant proportion of these deaths, precisely one-third, occurs in individuals under 70. Metabolic syndrome encompasses a range of diseases characterized by various physiological dysfunctions. These include increased inflammation in adipose tissue, enhanced cholesterol synthesis in the liver, impaired insulin secretion, insulin resistance, compromised vascular tone and integrity, endothelial dysfunction, and atheroma formation. These factors contribute to the development of metabolic disorders and significantly increase the likelihood of experiencing cardiovascular complications.Method: We selected studies that proposed hypotheses regarding metabolic disease syndrome and cardiovascular disease (CVD) and the role of Nrf2/HO-1 and factor regulation in CVD research investigations based on our searches of Medline and PubMed.Results: A total of 118 articles were included in the review, 16 of which exclusively addressed hypotheses about the role of Nrf2 on Glucose regulation, while 16 involved Cholesterol regulation. Likewise, 14 references were used to prove the importance of mitochondria on Nrf2. Multiple studies have provided evidence suggesting the involvement of Nrf2/HO-1 in various physiological processes, including metabolism and immune response. A total of 48 research articles and reviews have been used to highlight the role of metabolic syndrome and CVD.Conclusion: This review provides an overview of the literature on Nrf2/HO-1 and its role in metabolic disease syndrome and CVD.
Keywords: Metabolic syndrome; Nrf2/HO-1; cardiovascular diseases; mitochondrial; reactive oxygen stress.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures
![Figure 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10836253/bin/IANN_A_2284890_F0001_C.gif)
![Figure 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10836253/bin/IANN_A_2284890_F0002_C.gif)
![Figure 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10836253/bin/IANN_A_2284890_F0003_C.gif)
Similar articles
-
Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress.J Adv Res. 2021 Jul 6;34:43-63. doi: 10.1016/j.jare.2021.06.023. eCollection 2021 Dec. J Adv Res. 2021. PMID: 35024180 Free PMC article. Review.
-
Efficiency of Traditional Chinese medicine targeting the Nrf2/HO-1 signaling pathway.Biomed Pharmacother. 2020 Jun;126:110074. doi: 10.1016/j.biopha.2020.110074. Epub 2020 Mar 9. Biomed Pharmacother. 2020. PMID: 32163746 Review.
-
Cyanate Induces Oxidative Stress Injury and Abnormal Lipid Metabolism in Liver through Nrf2/HO-1.Molecules. 2019 Sep 5;24(18):3231. doi: 10.3390/molecules24183231. Molecules. 2019. PMID: 31491954 Free PMC article.
-
Effects of Polyphenolic Derivatives on Heme Oxygenase-System in Metabolic Dysfunctions.Curr Med Chem. 2018;25(13):1577-1595. doi: 10.2174/0929867324666170616110748. Curr Med Chem. 2018. PMID: 28618991 Review.
-
Synergistic Interaction Between Heme Oxygenase (HO) and Nuclear-Factor E2- Related Factor-2 (Nrf2) against Oxidative Stress in Cardiovascular Related Diseases.Curr Pharm Des. 2017;23(10):1465-1470. doi: 10.2174/1381612823666170113153818. Curr Pharm Des. 2017. PMID: 28088909 Review.
References
-
- Silveira Rossi JL, Barbalho SM, Reverete de Araujo R, et al. . Metabolic syndrome and cardiovascular diseases: going beyond traditional risk factors. Diabetes Metab Res Rev. 2022;38(3):e3502. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical